Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | The protective effect of NTF

Wipawan Thangnipon • 17 Apr 2019
ARUK 2019
Alzheimer’s Disease Dementia

Wipawan Thangnipon, PhD, of Mahidol University, Salaya, Thailand, speaks at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK and discusses her research into the protective role of N-trans-feruloyltyramine (NTF) against scopolamine-induced cholinergic dysfunction in a rat model.

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals